Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Cureus ; 14(6): e25643, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35795503

RESUMO

The auriculotemporal nerve is one branch of the mandibular portion of the trigeminal nerve, which itself divides into several branches in the temporal and retromandibular regions. The lesser occipital nerve is a cutaneous branch of the cervical plexus and is sometimes implicated in cases of cervicogenic headaches, occipitoparietal headaches, and occipital neuralgia, in general. Here, we present a case of unilateral neural interconnection between the auriculotemporal and lesser occipital nerves thus illustrating the joining of the cervical plexus and trigeminal nerve. A better understanding of the aforementioned nervous anatomy may be valuable for facial reconstructive and nerve transfer procedures, as well as for a variety of other head and neck disorders, e.g., occipital neuralgia.

3.
Clin Infect Dis ; 69(1): 167-178, 2019 06 18.
Artigo em Inglês | MEDLINE | ID: mdl-30395179

RESUMO

Bacteriophages (phages) may constitute a natural, safe, and effective strategy to prevent and control multidrug-resistant organisms (MDROs), and ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) pathogens in particular. Few clinical studies have assessed the safety and efficacy of phages in patients infected with MDROs. This systematic review summarizes and critically evaluates published studies of phages in clinical practice and presents the appropriate phage selection criteria, as well as recommendations for clinicians and scientists for a successful therapy. Articles were identified through a search of the PubMed, Ovid, EMBASE, and Cochrane Library databases. Among 1102 articles and abstracts, 30 studies were selected and evaluated using selective inclusion criteria, phage criteria, and study characteristics. Most studies showed efficacy (87%) and safety (67%) of the tested phages, but few studies examined phage resistance (35%). Clinical studies and regulatory changes are needed to determine the safety and efficacy of phages and to advance their use in patients with MDRO infections.


Assuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/terapia , Farmacorresistência Bacteriana Múltipla , Terapia por Fagos , Infecções por Acinetobacter/prevenção & controle , Infecções por Acinetobacter/terapia , Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Ensaios Clínicos como Assunto , Infecções por Bactérias Gram-Positivas/prevenção & controle , Infecções por Bactérias Gram-Positivas/terapia , Humanos , Infecções por Klebsiella/prevenção & controle , Infecções por Klebsiella/terapia , Infecções por Pseudomonas/prevenção & controle , Infecções por Pseudomonas/terapia , Infecções Estafilocócicas/prevenção & controle , Infecções Estafilocócicas/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...